Rhabdomyosarcoma (RMS) belongs to the soft tissue sarcomas that have striated muscle differentiation. It is most common in young children under 5 years of age and adolescents. The definite diagnosis of rhabdomyosarcoma is based on histology and the positivity of striated muscle markers in immunohistochemistry. Our objective was to describe the prognostic characteristics of RMS diagnosed in Dakar. MATERIAL AND METHODS: This was a retrospective and descriptive study spread over nine (09) years from 1 January 2011 to 31 December 2019. It was conducted from the histological report archives of the anatomy and pathology laboratories of Dakar. Paraffin blocks were reread and immunohistochemically studied by manual method. Antidesmin and antimyogenin antibodies were used. RESULTS: We collected 44 patients with rhabdomyosarcoma out of 228 cases of soft tissue cancers, i.e. 19.29% of all malignant soft tissue tumours. The mean age of the patients was 25.41 ± 23.95 (standard deviation) years with a median age of 16 years and extremes of 6 months and 81 years. Patients were less than or equal to 17 years of age in 61.4% of cases. A clear male predominance was observed with 29 men (65.9%) against 15 women (34.1%). Rhabdomyosarcomas were located in the limbs in 34.1% of cases, in the head and neck in 29.5% of cases and in the genitourinary tract in 25% of cases. The average tumour size was 7.45 cm ± 4.64 (standard deviation) with a minimum of 2 cm and a maximum of 17 cm. It was greater than or equal to 5 cm in 15 patients (68.2%). Embryonal rhabdomyosarcoma (ERMS) was the most frequent histological type with 34 cases (77.3%), followed by pleomorphic rhabdomyosarcoma 7 cases (15.9%) and alveolar rhabdomyosarcoma 3 cases (6.8%). The histological subtypes of ERMS consisted of conventional ERMS (91.18%); botryoid RMS (5.88%) and spindle cell RMS (2.94%). The correlation between histological type and age was statistically significant (p = 0.039). A relationship was also observed between histological type and site (p = 0.026). According to the American IRS classification, the tumour was classified as group I in 41% of cases, group II in 50% of cases and groups III and IV in 4.5% each. CONCLUSION: Rhabdomyosarcoma is a rare malignant tumour in Dakar. It is often a voluminous tumour of the limbs which affects mainly males. The embryonal type is the most frequent histological form.
References
[1]
Pizzo, P.A. and Poplack, D.G. (2006) Rhabdomyosarcoma and the Undifferentiated Sarcoma. In: Pizzo, P.A. and Poplack, D.G., Eds., Principles & Practice of Pediatric Oncology, 5th Edition, Lippincott Williams & Wilkins, Philadelphia, 971-996.
[2]
Sommelet, D., Pinkerton, R., Brunat-Mentigny, M., Farsi, F., Martel, I., Philip, T., et al. (1998) Standards, Options and Recommendations (SOR) for Clinical Care of Rhabdomyosarcoma (RMS) and Other Soft Tissue Sarcoma in Children. Federation of the French Cancer Centers. French Society of Pediatric Oncology. Bulletin du Cancer, 85, 1015-1042.
[3]
Zafad, S., Harif, M., Benchekroun, S., Zamiati, S. and Sqalli, S. (2002) Les rhabdomyosarcomes de l’enfant. Esp. Médicale, 9, 96-98.
[4]
Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., et al. (2003) Rhabdomyosarcoma in Adults. A Retrospective Analysis of 171 Patients Treated at a Single Institution. Cancer, 98, 571-580. https://doi.org/10.1002/cncr.11550
[5]
D’Andon, A., Hartmann, O., Vassal, G. and Oberlin, O. (2003) Malignant Mesenchymal Tumours or Soft Tissue Sarcomas. Institut Gustave-Roussy, Villejuif (France), 12 p.
[6]
Egas-Bejar, D. and Huh, W.W. (2014) Rhabdomyosarcoma in Adolescent and Young Adult Patients: Current Perspectives. Adolescent Health, Medicine and Therapeutics, 5, 115-125. https://doi.org/10.2147/AHMT.S44582
[7]
Dziuba, I., Kurzawa, P., Dopierała, M., Larque, A.B. and Januszkiewicz-Lewandowska, D. (2018) Rhabdomyosarcoma in Children—Current Pathologic and Molecular Classification. Polish Journal of Pathology, 69, 20-32. https://doi.org/10.5114/pjp.2018.75333
[8]
Badr, M.A., Al-Tonbary, Y.A., Mansour, A.K., Hassan, T.H., Beshir, M.R., Darwish, A., et al. (2012) Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study. International Scholarly Research Network Oncology, 2012, Article ID: 674523. https://doi.org/10.5402/2012/674523
[9]
Innocent, E., Manasseh, A.N., Badoe, E.V., Daniel, Y., Vandi, K.B., Olanrewaju, A., et al. (2018) Rhabdomyosarcoma in All Age Groups at the Jos University Teaching Hospital. West African Journal of Medicine, 35, 97-101.
[10]
Ahmad, Z., Ud Din, N., Ahmad, A., Imran, S., Pervez, S., Ahmed, R., et al. (2015) Rhabdomyosarcoma—An Epidemiological and Histopathologic Study of 277 Cases from a Major Tertiary Care Center in Karachi, Pakistan. Asian Pacific Journal of Cancer Prevention, 16, 757-760. https://doi.org/10.7314/APJCP.2015.16.2.757
[11]
Sultan, I., Qaddoumi, I., Yaser, S., Rodriguez-Galindo, C. and Ferrari, A. (2009) Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2600 Patients. Journal of Clinical Oncology, 27, 3391-3397. https://doi.org/10.1200/JCO.2008.19.7483
[12]
Shouman, T., EL-Kest, I., Zaza, K.H., Ezzat, M., William, H. and Ezzat, I. (2005) Rhabdomyosarcoma in Childhood: A Retrospective Analysis of 190 Patients Treated at a Single Institution. Journal of the Egyptian National Cancer Institute, 17, 67-75.
[13]
Bergeron, C., Ranchere-Vince, D. and Berard-Marec, P. (2002) News on Rhabdomyosarcoma in Children. Cancer Bulletin, 89, 108-112.
[14]
Dagher, R. and Helman, L. (1999) Rhabdomyosarcoma: An Overview. The Oncologist, 4, 34-44. https://doi.org/10.1634/theoncologist.4-1-34
[15]
Hosoi, H., Teramukai, S., Matsumoto, Y., Tsuchiya, K., Iehara, T., Hara, J., et al. (2007) A Review of 331 Rhabdomyosarcoma Cases in Patients Treated between 1991 and 2002 in Japan. International Journal of Clinical Oncology, 12, 137-145. https://doi.org/10.1007/s10147-006-0638-6
[16]
Bansal, D., Das, A., Trehan, A., Kapoor, R., Panda, N.K., Srinivasan, R., et al. (2017) Pediatric Rhabdomyosarcoma in India: A Single-Center Experience. Indian Pediatrics, 54, 735-738. https://doi.org/10.1007/s13312-017-1164-5
[17]
Wexler, L.H., Meyer, W.H. and Helman, L.J. (2006) Rhabdomyosarcoma and the Undifferentiated Sarcomas. In: Pizzo, P.A. and Poplack, D.G., Eds., Principles and Practice of Pediatric Oncology, 5th Edition, Lippincott Williams & Wilkins, Philadelphia, 971-1032.
[18]
Dumont, S.N., Araujo, D.M., Munsel, M.F., Salganick, J.A., Dumont, A.G., Raymond, K., et al. (2013) Management and Outcome of 239 Adolescent and Adult Rhabdomyosarcoma Patients. Cancer Medicine, 2, 553-563. https://doi.org/10.1002/cam4.92
[19]
Ognjanovic, S., Linabery, A.M., Bridget Charbonneau, B. and Ross, J.A. (2009) Trends in Childhood Rhabdomyosarcoma Incidence and Survival in the United States, 1975-2005. Cancer, 115, 4218-4226. https://doi.org/10.1002/cncr.24465
[20]
Aung, L., Soe, T.A., Chang, K.T.E. and Quah, T.C. (2014) Singapore Rhabdomyosarcoma (RMS) Experience: Shall We Change Our Practice? Annals of the Academy of Medicine of Singapore, 43, 86-95.
[21]
Missaoui, N., Landolsi, H., Jaidene, L., Anjorin, A., Ben Abdelkader, A., Yaacoubi, M.T., et al. (2010) Pediatric Rhabdomyosarcomas in Tunisia. Asian Pacific Journal of Cancer Prevention, 11, 1325-1327.
[22]
Brown, B.J. and Oluwasola, A.O. (2006) Childhood Rhabdomyosarcoma in Ibadan, Nigeria: 1984-2003. Annals of Tropical Paediatrics, 26, 349-355. https://doi.org/10.1179/146532806X152881
[23]
Galmiche, L. (2017) Anatomopathological Management of Pediatric Tumors. Francophone Laboratory Review, 488, 49-58. https://doi.org/10.1016/S1773-035X(16)30419-1
[24]
Ma, X., Huang, D., Zhao, W., Sun, L., Xiong, H., Zhang, Y., et al. (2015) Clinical Characteristics and Prognosis of Childhood Rhabdomyosarcoma: A Ten-Year Retrospective Multicenter Study. International Journal of Clinical and Experimental Medicine, 8, 17196-17205.
